Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	309.59	302.40	-73.83
Graham Fair Price	61.19	7077.68	4390.99
PEG	-85.38	0.02	-0.14
Price/Book	-9.26	0.30	0.33
Price/Cash Flow	-25.78	15.41	-20.77
Prices/Earnings	-63.82	3.16	8.72
Price/Sales	6.94	1.55	1.45
Price/FCF	-25.78	15.41	-20.77
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1002.27	0.05	< 0.005
Operating Margin	-94.08	< 0.005	-0.03
ROA	153.57	0.02	< 0.005
ROE	< 0.005	0.02	150.78
ROIC	< 0.005	< 0.005	69.35
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.14	0.52	-72.82
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.72	1.05	-39.00
EPS QOQ	-0.63	1.55	147.48
FCF QOQ	-2.59	2.24	-13.27
Revenue QOQ	0.06	-0.14	125.71
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	30.83	35.69	15.74
Days Sales Outstanding (DSO)	68.79	75.36	9.54
Inventory Turnover	2.92	2.52	-13.60
Debt/Capitalization	0.13	0.12	-13.61
Quick Ratio	0.98	0.99	1.22
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	9524.10	9694.07	1.78
Cash	452.24	465.14	2.85
Capex	-12.72	-1.20	90.59
Free Cash Flow	-151.20	188.14	24.43
Revenue	2162.18	1867.34	-13.64
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.32	1.33	0.96
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-22.83	89.50	291.96
Naive Interpretation	Member

06 - Financial Health · Weak

Rating